Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Knowing when to consider a financial advisor can make a difference in achieving your financial goals. Be proactive in your planning.
26,299 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Andersen Group surged on surprise Q4 strength and an optimistic outlook. This deep dive explains what drove the rally...
When a large manager trims a position, questions follow. This article breaks down Hilton Capital’s $25 million GPIX s...
A 73-year-old retiree with $1.6 million faces a long, uncertain horizon. New modeling suggests an 80/20 bond-heavy pl...
A combo of macro headwinds and a bigger-than-expected debt offering pushed Ciena shares lower. This guide breaks down...
Marvell Technology surged to new heights as whispers about AWS opening Trainium to external buyers drew investor atte...
In mid-June, hawkish central bank signals set the tone for global markets. The FTSE 100 faltered while the Nikkei 225...
Rocket Lab and AST SpaceMobile pursue different spacefrontiers, from reliable launches to space-based connectivity. T...
Smart investors look beyond the loud headlines. This guide explains how overlooked stocks soar 2026 by spotting catal...
This article breaks down United Parks PRKS 2026 Q1 earnings, highlighting revenue growth, margins, and the drivers sh...
A hypothetical $10,000 Exxon investment at the outbreak of the Iran conflict has produced a mixed bag of results. Her...
Yum! Brands is selling Pizza Hut in two moves, reshaping its portfolio. This could boost balance sheet strength and s...